{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:28:02Z","timestamp":1761294482167},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,12]]},"DOI":"10.7759\/cureus.25885","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:32:46Z","timestamp":1655098366000},"source":"Crossref","is-referenced-by-count":1,"title":["Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease Treated With Autologous Stem Cell Transplantation Using a Modified TEAM Regimen"],"prefix":"10.7759","author":[{"given":"Kudret","family":"Kama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"La Ros\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bosch-Schips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Illerhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90.","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02426.x","article-title":"An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome","volume":"111","author":"Murase T","year":"2000","unstructured":"Murase T, Nakamura S, Kawauchi K, et al.. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000, 111:826-34. 10.1111\/j.1365-2141.2000.02426.x","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07338.x","article-title":"The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma","volume":"143","author":"Ferreri AJ","year":"2008","unstructured":"Ferreri AJ, Dognini GP, Bairey O, et al.. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma. Br J Haematol. 2008, 143:253-7. 10.1111\/j.1365-2141.2008.07338.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4278","article-title":"Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan","volume":"26","author":"Shimada K","year":"2008","unstructured":"Shimada K, Matsue K, Yamamoto K, et al.. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008, 26:3189-95. 10.1200\/JCO.2007.15.4278","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30059-0","article-title":"Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial","volume":"21","author":"Shimada K","year":"2020","unstructured":"Shimada K, Yamaguchi M, Atsuta Y, et al.. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020, 21:593-602. 10.1016\/S1470-2045(20)30059-0","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1239-7","article-title":"Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome","volume":"91","author":"Tabata C","year":"2012","unstructured":"Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome. Ann Hematol. 2012, 91:63-71. 10.1007\/s00277-011-1239-7","journal-title":"Ann Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218808074","article-title":"Pharmacokinetics of cisplatin in an esophageal cancer patient on hemodialysis who was treated with a full-dose cisplatin-fluorouracil regimen: a case report","volume":"25","author":"Amagai H","year":"2019","unstructured":"Amagai H, Murakami K, Sakata H, et al.. Pharmacokinetics of cisplatin in an esophageal cancer patient on hemodialysis who was treated with a full-dose cisplatin-fluorouracil regimen: a case report. J Oncol Pharm Pract. 2019, 25:1767-75. 10.1177\/1078155218808074","journal-title":"J Oncol Pharm Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.339","article-title":"Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience","volume":"52","author":"Meissner J","year":"2017","unstructured":"Meissner J, Finel H, Dietrich S, et al.. Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplant. 2017, 52:650-2. 10.1038\/bmt.2016.339","journal-title":"Bone Marrow Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0035","article-title":"Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study","volume":"105","author":"Bhatia S","year":"2005","unstructured":"Bhatia S, Robison LL, Francisco L, et al.. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005, 105:4215-22. 10.1182\/blood-2005-01-0035","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment","volume":"34","author":"Dimopoulos MA","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N, et al.. International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol. 2016, 34:1544-57. 10.1200\/JCO.2015.65.0044","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0171-7","article-title":"AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity","volume":"88","author":"Lindner LH","year":"2008","unstructured":"Lindner LH, Ostermann H, Hiddemann W, et al.. AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity. Int J Hematol. 2008, 88:381-6. 10.1007\/s12185-008-0171-7","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh008","article-title":"Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis","volume":"15","author":"Inoue A","year":"2004","unstructured":"Inoue A, Saijo Y, Kikuchi T, et al.. Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis. Ann Oncol. 2004, 15:51-4. 10.1093\/annonc\/mdh008","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0757-z","article-title":"Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency","volume":"63","author":"Ekhart C","year":"2009","unstructured":"Ekhart C, Kerst JM, Rodenhuis S, Beijnen JH, Huitema AD. Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency. Cancer Chemother Pharmacol. 2009, 63:375-9. 10.1007\/s00280-008-0757-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200107000-00005","article-title":"Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin","volume":"12","author":"van Maanen MJ","year":"2001","unstructured":"van Maanen MJ, Huitema AD, Rodenhuis S, Beijnen JH. Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin. Anticancer Drugs. 2001, 12:519-24. 10.1097\/00001813-200107000-00005","journal-title":"Anticancer Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99354-hemophagocytic-syndrome-associated-intravascular-large-b-cell-lymphoma-with-dialysis-dependent-end-stage-renal-disease-treated-with-autologous-stem-cell-transplantation-using-a-modified-team-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:15Z","timestamp":1707507435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99354-hemophagocytic-syndrome-associated-intravascular-large-b-cell-lymphoma-with-dialysis-dependent-end-stage-renal-disease-treated-with-autologous-stem-cell-transplantation-using-a-modified-team-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.25885","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,12]]}}}